ethris – Enabling Therapies

Ethris develops innovative therapeutics based on proprietary platform technologies with high diversification potential that enable therapies for diseases with currently dissatisfying treatment options.

>>>

IMAGINE...
GENE THERAPY WITHOUT GENES

NEWS

January 7, 2013
Ethris announces research based alliance on SNIM® modified RNA with Shire

Ethris GmbH and Shire today announce the initiation of a research based alliance focused on the development and commercialization of novel RNA-based therapeutics.

>>>
May 26, 2011
Research project of € 3.2 million is among the winners of the BMBF call “Go-Bio”

With its project “SNIM® RNA – a new class of RNA biopharmaceuticals” ethris is among the winners of the 4th Selection round of the “Go-Bio” call…

>>>

GET IN TOUCH

ethris GmbH
Lochhamer Str. 11
82152 Martinsried
Deutschland

T +49 89 89 55 788 11
F +49 89 89 55 788 18

info@ethris.com

OUR TECHNOLOGY

Ethris explores the code of life for enabling patients’ bodies to make their own protein drugs. The proprietary SNIM®RNA platform and tailor-made delivery systems for systemic, local, oral and aerosol administration reduce gene therapy without genes to practice of medical need. SNIM®RNA “Transcript Therapies” are unprecedented treatment options for numerous diseases.

>>>